Floatz logo

Vinorelbine Ditartrate

Lung Large Cell Carcinoma

AIO-Studien-gGmbHSmall moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Lung Large Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
National Cancer Institute (NCI)
Phase 4A
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 3BBB
ETOPOSIDE
Barbara Ann Karmanos Cancer Institute
Phase 3BBB
Gefitinib
National Cancer Institute (NCI)
Phase 3BB
Docetaxel
Korean South West Oncology Group
Phase 3BB

View all 31 →

Same molecule, other indications

Vinorelbine Ditartrate is also rated in:

Hodgkins lymphomaActive
BBB
Indicative · Phase 3
72 / 100
View asset →
cervical cancerDormant
BBB
Indicative · Phase 2
72 / 100
View asset →
non-small cell lung carcinomaActive
BB
Indicative · Phase 4
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →